Search Knowledge Base

8 results for "deferiprone"

Oral deferiprone for iron chelation in people with thalassaemia pubmed_article
Evidence Source 2007 PMID: 17636775
Oral deferiprone for iron chelation in people with thalassaemia pubmed_article
Evidence Source 2013 PMID: 23966105
A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia pubmed_article
Evidence Source 2014 PMID: 25307964
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 35878782
Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38334258
Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis pubmed_article
Evidence Source PMID: 29727586
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2005 PMID: 16235363
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2013 PMID: 23963793

Evidence Search Results semantic · quality-ranked

Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 73 2024 PMID: 38334258 DOI: 10.1111/cns.14607
No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 51 2023 PMID: 35878782 DOI: 10.1016/j.tracli.2022.07.004
Oral deferiprone for iron chelation in people with thalassaemia meta_analysis pubmed_article
Quality: 71 2013 PMID: 23966105 DOI: 10.1002/14651858.CD004839.pub3
Oral deferiprone for iron chelation in people with thalassaemia meta_analysis pubmed_article
Quality: 65 2007 PMID: 17636775
A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia meta_analysis pubmed_article
Quality: 60 2014 PMID: 25307964 DOI: 10.3109/03630269.2014.965781
Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 56 2025 PMID: 39993479 DOI: 10.1016/j.ctim.2025.103151
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 67 2017 PMID: 28809446 DOI: 10.1002/14651858.CD007476.pub3
Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review systematic_review pubmed_article
Quality: 56 2022 PMID: 35855073 DOI: 10.12688/wellcomeopenres.17505.3
Targeting ferroptosis with flavonoids for cancer therapy: Mechanisms and opportunities systematic_review pubmed_article
Quality: 50 2026 PMID: 41483837 DOI: 10.1016/j.bbcan.2025.189528
Time-dose response and mechanistic specificity of berberine in renal fibrosis from a multi-model integration perspective: a systematic review and meta-analysis on animal models systematic_review pubmed_article
Quality: 50 2025 PMID: 40567371 DOI: 10.3389/fphar.2025.1600408

View full evidence search →